# Understanding Cannabis-Induced Psychosis and Psychiatric Progression > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-induced-psychosis-schizophrenia-bipolar-progression-guide/ > **Published:** 2026-04-25T11:08:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:54:55-04:00 > **Clinical Summary:** Explore cannabis-induced psychosis schizophrenia bipolar progression and clinical research insights on risk and long-term psychiatric outcomes. --- #### Clinical Takeaway Clinical Takeaway Patients presenting with cannabis-induced psychosis have measurable risk for developing schizophrenia spectrum or [bipolar disorder](https://cedclinic.com/cannabis-induced-appetite-satiety-bypass-thc-brain/), though distinguishing these primary psychiatric conditions from acute cannabis effects remains clinically challenging. Long-term psychiatric monitoring and standardized diagnostic protocols are necessary following cannabis-induced psychotic episodes to identify individuals at risk for persistent mental illness. ### #25 Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis. **Citation:** Javed Mohammad Saad et al. *Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis.* BMC psychiatry. 2026. PMID: 41664079. **Study type:** Journal Article, Systematic Review, Meta-Analysis  |  **Topic area:** Psychosis  |  **CED Score:** 10 Design: 6 Journal: 0 N: 0 Recency: 3 Pop: 2 Human: 1 Risk: -2 **Quality Gate Alerts:** - Preclinical only **Abstract:** BACKGROUND: Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications. Current treatment approaches lack standardized guidelines, potentially leading to the development of schizophrenia spectrum and bipolar disorder. This study systematically reviews the literature and provides a pooled prevalence of later developing these disorders following a cannabis-induced psychosis diagnosis. METHODS: We systematically reviewed Medline, Embase, Web of Science, Google Scholar, and PsychInfo for studies reporting on a group of patients with cannabis-induced psychosis and subsequent diagnoses of schizophrenia spectrum disorder, bipolar disorder, or both. The search was conducted until January 1, 2025. A modified version of the Newcastle-Ottawa scale was used to assess study quality. Random-effects meta-analyses were conducted to calculate pooled mean prevalence. Random-effects meta-regressions were used to identify predictors of higher prevalence. RESULTS: Our strategy identified 13 studies eligible for inclusion with a total population size of 7,515 which reported a total of 16 outcomes of interest. Among cannabis induced psychosis patients, 20% (95% CI:15.8-29.5%) later received a schizophrenia spectrum diagnosis, 5% (95% CI:2.7-6.9%) bipolar and 63% (95% CI:26.8-90.5%) unspecified (both). Compared to individuals receiving a later schizophrenia spectrum disorder diagnosis, patients were 76% less likely to develop bipolar disorder. Later diagnosis of an unspecified disorder showed an approximate 3 folds higher risk with an ARR of 2.52 (95% CI: 1.03-6.15) compared to schizophrenia spectrum disorder alone. CONCLUSIONS: Approximately one in five patients diagnosed with cannabis-induced psychosis will develop schizophrenia spectrum disorder, while one in twenty will be later diagnosed with bipolar disorder.  |   |  [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41664079/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12922385/)[DOI ↗](https://doi.org/10.1186/s12888-025-07382-2) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Prevalence of Schizophrenia Spectrum and Bipolar Disorder in Cannabis Induced Psychosis Patients](https://cedclinic.com/cannabis-induced-psychosis-prevalence-schizophrenia-bipolar/) A detailed review of schizophrenia and bipolar disorder prevalence among cannabis-induced psychosis patients. [Read More](https://cedclinic.com/cannabis-induced-psychosis-prevalence-schizophrenia-bipolar/) [Cannabis Induced Psychosis: Systematic Review & Meta-Analysis on Schizophrenia Spectrum & Bipolar Disorder](https://cedclinic.com/cannabis-induced-psychosis-prevalence-schizophrenia-bipolar/) Comprehensive meta-analysis exploring the progression from cannabis-induced psychosis to schizophrenia and bipolar disorder. [Explore Study](https://cedclinic.com/cannabis-induced-psychosis-prevalence-schizophrenia-bipolar/) [`Cannabis-Induced Psychosis & Schizophrenia Risk: Key Research`](https://cedclinic.com/cannabis-induced-psychosis-schizophrenia-progression-insights/) Key research findings on the risk of schizophrenia following cannabis-induced psychosis. [Learn More](https://cedclinic.com/cannabis-induced-psychosis-schizophrenia-progression-insights/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Understanding%20Cannabis-Induced%20Psychosis%20and%20Psychiatric%20Progression&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-induced-psychosis-schizophrenia-bipolar-progression-guide%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-induced-psychosis-schizophrenia-bipolar-progression-guide%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Understanding%20Cannabis-Induced%20Psychosis%20and%20Psychiatric%20Progression%20https%3A%2F%2Fcedclinic.com%2Fcannabis-induced-psychosis-schizophrenia-bipolar-progression-guide%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).